- atropine sulfate
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original can be viewed in PDF format using the link above.
The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet is: PL 02848/5912.
Atropine Sulphate Injection BP 600 micrograms/1ml
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
Atropine Sulphate 600 micrograms/ml
Solution for Injection
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
The name of your medicine is Atropine Sulphate 600 micrograms/ml Solution for Injection. It will be referred to as Atropine Sulphate Injection for ease hereafter.
What is in this leaflet:
1. What Atropine Sulphate Injection is and what it is used for
2. What you need to know before you are given Atropine Sulphate Injection
3. How you are given Atropine Sulphate Injection
4. Possible side effects
5. How to store Atropine Sulphate Injection
6. Contents of the pack and other information
1. WHAT ATROPINE SULPHATE INJECTION IS AND WHAT IT IS USED FOR
Atropine Sulphate Injection contains the active substance Atropine Sulphate which belongs to a group of medicines called cholinesterase inhibitors. It has the effect of reversing the action of certain muscle-relaxing drugs. The effects of atropine include an increase in heart rate, a decrease in production of saliva, sweat, bronchial and intestinal secretions, and a decrease in the movements of the intestine.
Atropine Sulphate Injection is used in the following conditions:
2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN ATROPINE SULPHATE INJECTION
You should not be given Atropine Sulphate Injection
Make sure your doctor knows if you suffer from any of these.
Warnings and precautions
Talk to your doctor, nurse or pharmacist before you are given Atropine Sulphate Injection:
Tell your doctor if any of these apply to you.
Other medicines and Atropine Sulphate Injection
Tell your doctor, nurse or pharmacist if you are taking or have recently taken any other medicines. This includes any herbal products or medicines bought without a prescription.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Atropine Sulphate Injection should only be used during pregnancy when your doctor decides the benefits to you are greater than any possible risk to the unborn baby.
Atropine Sulphate Injection should only be used during breast-feeding when your doctor decides the benefits to you are greater than any possible risk to the breast-feeding infant.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Atropine Sulphate injection may cause drowsiness, blurred vision, confusion and hallucinations and patients should be advised not to drive or operate machinery if affected.
3. HOW YOU ARE GIVEN ATROPINE SULPHATE INJECTION
Atropine Sulphate Injection is administered by injection into a vein, into the muscle or into the tissue just beneath the skin.
Your doctor will decide the correct dose for you, depending on your circumstances. Your dose may be calculated according to your age, body weight, severity of the symptoms and previous responses to similar medicines.
If you are given more Atropine Sulphate Injection than you should
This is unlikely because the dose will be administered by a healthcare professional. An overdose may cause difficulty in breathing, restlessness, hallucinations (seeing things that are not there) and occasionally convulsions. If you suspect you have been given too much, you should tell the doctor immediately.
If you have any further questions on the use of this product ask your doctor.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious and you should tell your doctor immediately if you notice the following:
The following side effects have also been reported:
Very rare (may affect up to 1 in 10,000 people)
Not known: frequency cannot be estimated from the available data
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
5. HOW TO STORE ATROPINE SULPHATE INJECTION
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label, carton. The expiry date refers to the last day of that month.
Do not store above 25°C.
Keep in original container in order to protect from light.
If only part used, discard the remaining solution.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Atropine Sulphate Injection contains
The active substance is Atropine Sulphate. Each ampoule contains 600 micrograms of Atropine Sulphate in 1ml of solution.
The other ingredients of the each ampoule are dilute sulphuric acid and water for injections.
What Atropine Sulphate Injection looks like and contents of the pack
Atropine Sulphate Injection is a clear, colourless sterile solution for injection.
Each glass ampoule (a small bottle) contains 1ml of solution which contains 600 micrograms of Atropine Sulphate.
Each carton contains ten 1ml ampoules of Atropine Sulphate Injection.
Marketing Authorisation Holder
This leaflet was last revised in December 2018.
Capital House, 1st Floor, 85 King William Street, London, EC4N 7BL, UK
+44 (0)208 588 9131
08700 70 30 33
+44 (0)208 588 9273